BRPI1008598A2 - composição farmacêutica para inalação - Google Patents

composição farmacêutica para inalação

Info

Publication number
BRPI1008598A2
BRPI1008598A2 BRPI1008598A BRPI1008598A BRPI1008598A2 BR PI1008598 A2 BRPI1008598 A2 BR PI1008598A2 BR PI1008598 A BRPI1008598 A BR PI1008598A BR PI1008598 A BRPI1008598 A BR PI1008598A BR PI1008598 A2 BRPI1008598 A2 BR PI1008598A2
Authority
BR
Brazil
Prior art keywords
inhalation
pharmaceutical composition
pharmaceutical
composition
Prior art date
Application number
BRPI1008598A
Other languages
English (en)
Inventor
David Alexander Vodden Morton
Morgane Lejeune
Yorick Kamlag
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Sa filed Critical Sanofi Sa
Publication of BRPI1008598A2 publication Critical patent/BRPI1008598A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
BRPI1008598A 2009-02-18 2010-02-18 composição farmacêutica para inalação BRPI1008598A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP09153082A EP2221048A1 (en) 2009-02-18 2009-02-18 Pharmaceutical composition for inhalation
PCT/EP2010/052026 WO2010094731A2 (en) 2009-02-18 2010-02-18 Pharmaceutical composition for inhalation

Publications (1)

Publication Number Publication Date
BRPI1008598A2 true BRPI1008598A2 (pt) 2016-03-15

Family

ID=40810348

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI1008598A BRPI1008598A2 (pt) 2009-02-18 2010-02-18 composição farmacêutica para inalação

Country Status (29)

Country Link
US (1) US8840930B2 (pt)
EP (2) EP2221048A1 (pt)
JP (1) JP2012517987A (pt)
KR (1) KR20110120283A (pt)
CN (1) CN102325523B (pt)
AR (1) AR075516A1 (pt)
AU (1) AU2010215490B2 (pt)
BR (1) BRPI1008598A2 (pt)
CA (1) CA2749231C (pt)
CY (1) CY1119216T1 (pt)
DK (1) DK2398464T3 (pt)
EA (1) EA021123B1 (pt)
ES (1) ES2607210T3 (pt)
HK (1) HK1160034A1 (pt)
HR (1) HRP20170014T1 (pt)
HU (1) HUE030618T2 (pt)
IL (1) IL214036A (pt)
LT (1) LT2398464T (pt)
MX (1) MX341250B (pt)
NZ (1) NZ594026A (pt)
PL (1) PL2398464T3 (pt)
PT (1) PT2398464T (pt)
RS (1) RS55527B1 (pt)
RU (1) RU2493833C2 (pt)
SI (1) SI2398464T1 (pt)
SM (1) SMT201700095B (pt)
UA (1) UA102138C2 (pt)
WO (1) WO2010094731A2 (pt)
ZA (1) ZA201105532B (pt)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8236786B2 (en) 2008-08-07 2012-08-07 Pulmagen Therapeutics (Inflammation) Limited Respiratory disease treatment
WO2012049444A1 (en) * 2010-10-12 2012-04-19 Cipla Limited Pharmaceutical composition
CN102451173B (zh) * 2010-10-22 2015-02-18 山东新时代药业有限公司 噻托溴铵胶囊型吸入粉雾剂
TR201105367A2 (tr) * 2011-06-02 2012-12-21 Bi̇lgi̇ç Mahmut Akış özellikleri geliştirilmiş bir kuru toz formülasyonu.
TR201205852A2 (tr) * 2011-06-02 2012-12-21 Bi̇lgi̇ç Mahmut Geliştirilmiş yeni kuru toz formülasyonu.
WO2014028587A1 (en) * 2012-08-14 2014-02-20 Newgen Biopharma Corp. Compositions comprising chitosan-drug conjugates and methods of making and using the same
CN103860525B (zh) * 2012-12-11 2016-04-06 天津药物研究院 一种含有效成分安立生坦的胶囊型吸入粉雾剂及其制备工艺
KR20160030086A (ko) * 2013-04-29 2016-03-16 사노피 에스에이 흡입식 약학적 조성물 및 그를 포함하는 흡입기 장치
AU2014261538A1 (en) * 2013-04-29 2015-12-10 Sanofi Sa Inhalable pharmaceutical compositions and the inhaler devices containing them
EP2815739B1 (en) * 2013-06-17 2019-08-28 Arven Ilac Sanayi Ve Ticaret A.S. Inhalation composition filling method
UA118861C2 (uk) * 2013-12-06 2019-03-25 Оріон Корпорейшн Спосіб отримання сухих порошкових композицій для інгаляцій
CN103784449A (zh) * 2014-02-18 2014-05-14 青岛市城阳区人民医院 一种包含茚达特罗和噻托溴铵的药物组合产品
PT109030B (pt) * 2015-12-15 2019-09-25 Hovione Farmaciência, S.A. Preparação de partículas inaláveis de zafirlucaste
CN107095875B (zh) * 2016-02-23 2022-03-18 天津金耀集团有限公司 一种昔奈酸沙美特罗丙酸氟替卡松复方粉吸入剂组合物
CN108066329B (zh) * 2016-11-11 2021-11-16 江苏恒瑞医药股份有限公司 一种吸入用氟替卡松或其衍生物的微粒的制备方法
CN107823193B (zh) * 2017-11-16 2021-02-05 广州迈达康医药科技有限公司 一种阿地溴铵吸入型粉雾剂及其制备方法
PL3833964T3 (pl) 2018-08-07 2023-09-04 Norton (Waterford) Limited Zastosowanie spektroskopii ramana do produkcji proszków do inhalacji
KR20230066364A (ko) 2020-08-14 2023-05-15 노턴 (워터포드) 리미티드 플루티카손 프로피오네이트 및 알부테롤 술페이트의 흡입가능 제제
WO2022146255A1 (en) * 2020-12-31 2022-07-07 Arven Ilac Sanayi Ve Ticaret Anonim Sirketi A process for the preparation of dry powder compositions for inhalation

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4140689B4 (de) * 1991-12-10 2007-11-22 Boehringer Ingelheim Kg Inhalationspulver und Verfahren zu ihrer Herstellung
JP2001517692A (ja) 1997-09-29 2001-10-09 インヘール セラピューティック システムズ， インコーポレイテッド ネブライザにおける使用のための安定化調製物
ITMI991582A1 (it) * 1999-07-16 2001-01-16 Chiesi Farma Spa Polveri costituite da particelle aventi la superficie perfettamente levigata da utilizzare come veicoli per la preparazione di miscele inala
DE19947235A1 (de) * 1999-09-30 2001-04-05 Asta Medica Ag Neue Kombination von Loteprednol und beta¶2¶-Adrenorezeptor-Agonisten
GB0012260D0 (en) * 2000-05-19 2000-07-12 Astrazeneca Ab Novel composition
AU2002333644A1 (en) 2001-09-17 2003-04-01 Glaxo Group Limited Dry powder medicament formulations
WO2003086358A1 (en) * 2002-04-12 2003-10-23 Campina Nederland Holding B.V. Excipient for use in dry powder inhalation preparations
GB2395900A (en) * 2002-12-04 2004-06-09 Elan Drug Delivery Ltd Therapeutic composition for respiratory delivery
US20040152720A1 (en) * 2002-12-20 2004-08-05 Boehringer Ingelheim Pharma Gmbh & Co. Kg Powdered medicaments containing a tiotropium salt and salmeterol xinafoate
EP1718336B1 (en) * 2004-02-06 2008-06-25 MEDA Pharma GmbH & Co. KG Novel combination of anticholinergic and beta mimetics for the treatment of respiratory diseases
CA2601179A1 (en) 2005-03-16 2006-09-21 Elan Pharma International Limited Nanoparticulate leukotriene receptor antagonist/corticosteroid formulations
GB0714134D0 (en) * 2007-07-19 2007-08-29 Norton Healthcare Ltd Dry-powder medicament

Also Published As

Publication number Publication date
SI2398464T1 (sl) 2017-05-31
UA102138C2 (uk) 2013-06-10
WO2010094731A3 (en) 2011-06-30
RS55527B1 (sr) 2017-05-31
CY1119216T1 (el) 2018-02-14
MX341250B (es) 2016-08-12
CN102325523A (zh) 2012-01-18
IL214036A0 (en) 2011-08-31
RU2011133322A (ru) 2013-03-27
PL2398464T3 (pl) 2017-09-29
IL214036A (en) 2015-08-31
EP2221048A1 (en) 2010-08-25
MX2011008659A (es) 2011-12-16
AR075516A1 (es) 2011-04-06
PT2398464T (pt) 2017-01-20
ZA201105532B (en) 2012-04-25
JP2012517987A (ja) 2012-08-09
HRP20170014T1 (hr) 2017-05-05
SMT201700095B (is) 2017-03-08
CA2749231C (en) 2016-09-13
KR20110120283A (ko) 2011-11-03
EA201190108A1 (ru) 2012-01-30
EP2398464B1 (en) 2016-11-02
EP2398464A2 (en) 2011-12-28
US8840930B2 (en) 2014-09-23
RU2493833C2 (ru) 2013-09-27
US20120071449A1 (en) 2012-03-22
DK2398464T3 (en) 2017-02-06
CA2749231A1 (en) 2010-08-26
AU2010215490B2 (en) 2014-01-16
NZ594026A (en) 2013-09-27
ES2607210T3 (es) 2017-03-29
AU2010215490A1 (en) 2011-08-04
HK1160034A1 (zh) 2012-08-10
WO2010094731A2 (en) 2010-08-26
EA021123B1 (ru) 2015-04-30
CN102325523B (zh) 2015-03-04
HUE030618T2 (en) 2017-05-29
LT2398464T (lt) 2017-03-10

Similar Documents

Publication Publication Date Title
BRPI1008598A2 (pt) composição farmacêutica para inalação
SMT201700008B (it) Composizione farmaceutica
DK3097925T3 (da) Farmaceutisk sammensætning
SMT201600350B (it) Composizioni farmaceutiche
BRPI1004940A2 (pt) composição farmacêutica
DK3246018T3 (da) Farmaceutisk sammensætning
BRPI0918971A2 (pt) tienopirimidinas para composições farmacêuticas
DK2694038T3 (da) Farmaceutisk sammensætning
BRPI1015939A2 (pt) composição farmacêutica
BRPI0919466A2 (pt) composição farmacêutica para liberação modificada
BR112012012108A2 (pt) composição farmacêutica compreendendo propofol
BRPI1012539A2 (pt) composições farmacêuticas
EE201300005A (et) Ravimkoostis
SG11201400580VA (en) Pharmaceutical composition for inhalation
BR112012004080A2 (pt) composições farmacêuticas para tratar ibd
IT1394400B1 (it) Composizioni farmaceutiche
DK2391349T3 (da) Farmaceutisk sammensætning omfattende 2-oco-1-pyrrolidin-derivater
BR112012000831A2 (pt) compostos, composições farmacêuticas e métodos relacionados
BRPI1007484A2 (pt) composição farmacêutica para administração oral
BRPI0922653A2 (pt) preparação farmacêutica
CO6801722A2 (es) Composiciones farmacéuticas
SMT201500005B (it) Composizione framaceutica inalabile
BR112012003149A2 (pt) composição farmacêutica
BRPI1005932A2 (pt) composto, composição farmacêutica para inalação e inalador
BR112012001340A2 (pt) composições farmacêuticas

Legal Events

Date Code Title Description
B25G Requested change of headquarter approved

Owner name: SANOFI SA (CH)

B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B06T Formal requirements before examination [chapter 6.20 patent gazette]
B11E Dismissal acc. art. 34 of ipl - requirements for examination incomplete
B11T Dismissal of application maintained [chapter 11.20 patent gazette]